Open Actively Recruiting

A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma

About

Brief Summary

The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness of AU-011 and standard of care therapy. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

Study Type
Observational
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

  • Have been clinically diagnosed with primary IL or CM at the time of entry to a previous Aura Biosciences sponsored clinical trial.
  • Have received AU-011 or assigned to an observation cohort in a previous Aura sponsored clinical trial.

Exclusion Criteria:

  • None

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
19-002053
Category
Oncology
Ophthalmology
Contact
Rosaleen Ostrick
Location
  • UCLA Westwood
For Providers
NCT No.
NCT03941379
For detailed technical eligibility, visit ClinicalTrials.gov.